High-Risk HPV Present in Subset of Penile Carcinomas

This article originally appeared here.
Share this content:
High-Risk HPV Present in Subset of Penile Carcinomas
High-Risk HPV Present in Subset of Penile Carcinomas

(HealthDay News) – High-risk human papillomavirus (hrHPV) infection is found in a subset of penile squamous cell carcinomas (PSCCs) that may develop from undifferentiated penile intraepithelial neoplasia (PeIN), according to a study published online Aug. 6 in the Journal of the American Academy of Dermatology.

Carla Ferrándiz-Pulido, MD, from the Hospital Universitari Vall d'Hebron in Barcelona, Spain, and colleagues examined the prevalence of HPV in a retrospective series of 82 patients with PSCC (69 invasive and 13 PeIN). Polymerase chain reaction assay with SPF-10 broad-spectrum primers followed by DNA enzyme immunoassay was used for HPV detection, and genotyping was performed using a reverse hybridization line probe assay.

The researchers identified HPV DNA in 31 of 77 (40.2%) PSCC cases (22 of 67 invasive and 9 of 10 PeIN). HPV-16 was identified in 25 of 31 (80.6%) cases. Most basaloid and warty tumors were hrHPV positive, while only 15% of usual PSCC were hrHPV positive. All hrHPV-positive PSCC had an adjacent undifferentiated PeIN. The researchers found that hrHPV infection correlated with strong p16INK4a immunostaining, and p16INK4a immunohistochemical overexpression was present in most undifferentiated PeIN. There was better overall survival, although not statistically significant, in both hrHPV-positive and p16INK4a-positive tumors.

"In this study, we detected hrHPV in 28% of PSCC and in 90% of PeIN," the authors write. "These results allow identification of a subset of PSCC in which HPV would play a triggering role and give support to the bimodal etiopathogenic hypothesis that distinguishes 2 different subsets of PSCC."

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs